Skip to Content

SEC Filings

Filing date	Form	Description	View
Mar 30, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-090100.pdf 0001193125-20-090100.rtf 0001193125-20-090100.xls View HTML
Mar 13, 2020	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-20-072857.pdf 0001193125-20-072857.rtf 0001193125-20-072857.xls View HTML
Mar 12, 2020	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-20-010531.pdf 0001564590-20-010531.rtf 0001564590-20-010531.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Feb 21, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-044782.pdf 0001193125-20-044782.rtf 0001193125-20-044782.xls View HTML
Feb 14, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-20-021226.pdf 0001104659-20-021226.rtf 0001104659-20-021226.xls View HTML
Feb 14, 2020	SC 13G/A	An amendment to the SC 13G filing	0000921895-20-000542.pdf 0000921895-20-000542.rtf 0000921895-20-000542.xls View HTML
Feb 12, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001258897-20-001153.pdf 0001258897-20-001153.rtf 0001258897-20-001153.xls View HTML
Dec 03, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-304912.pdf 0001193125-19-304912.rtf 0001193125-19-304912.xls View HTML
Dec 03, 2019	8-A12G	Registration of certain classes of securities 12(g) of the Securities Exchange Act	0001193125-19-304913.pdf 0001193125-19-304913.rtf 0001193125-19-304913.xls View HTML
Nov 19, 2019	SC 13D/A	An amendment to a SC 13D filing	0000921895-19-002823.pdf 0000921895-19-002823.rtf 0000921895-19-002823.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-441-1000
info@merrimack.com

© 2020 Merrimack Pharmaceuticals.